Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Guy Boeckxstaens, Katholieke Universiteit Leuven
ClinicalTrials.gov Identifier:
NCT01144832
First received: May 28, 2010
Last updated: January 27, 2016
Last verified: January 2016